In agreement with our findings, caffeic acid has previously been reported to be a potentially effective therapy for asthma, possessing various immunomodulatory, anti-inflammatory, and antioxidative effects via the MAPK, cyclooxygenase-2, NF-κB, and AMPK pathways [27–29]. This evidence concerns the gene PTGS2 and asthma.